Edward White

Stock Analyst at HC Wainwright & Co.

(1.85)
# 3,297
Out of 5,045 analysts
358
Total ratings
30.49%
Success rate
-8.03%
Average return

Stocks Rated by Edward White

Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $7.56
Upside: +336.51%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $9.13
Upside: +86.20%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $5.03
Upside: +198.21%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.00
Upside: +100.00%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20$16
Current: $1.49
Upside: +973.83%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.46
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $9.46
Upside: +746.09%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.38
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $3.94
Upside: +407.61%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.80
Upside: -
Maintains: Buy
Price Target: $15$16
Current: $4.04
Upside: +296.04%
Maintains: Buy
Price Target: $22$25
Current: $6.08
Upside: +311.18%
Reiterates: Buy
Price Target: $8
Current: $1.32
Upside: +506.06%
Reiterates: Neutral
Price Target: n/a
Current: $18.04
Upside: -
Reiterates: Neutral
Price Target: n/a
Current: $0.78
Upside: -
Reiterates: Buy
Price Target: $55
Current: $34.02
Upside: +61.67%
Reiterates: Buy
Price Target: $51
Current: $13.39
Upside: +280.88%
Reiterates: Buy
Price Target: $7
Current: $5.46
Upside: +28.21%
Maintains: Buy
Price Target: $7$56
Current: $5.96
Upside: +839.60%
Reiterates: Buy
Price Target: $31
Current: $10.40
Upside: +198.08%
Initiates: Neutral
Price Target: n/a
Current: $0.94
Upside: -
Initiates: Buy
Price Target: $700
Current: $9.30
Upside: +7,426.88%
Maintains: Buy
Price Target: $34$30
Current: $31.60
Upside: -5.06%
Downgrades: Neutral
Price Target: $12
Current: $1.29
Upside: +830.23%